URGN - CIK 0001668243
UroGen Pharma Ltd. has filed 549 documents with the SEC between 2016 and 2026. The most frequent type is insider trade (182 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Annual report | 10-K | 2023-03-24 | 2022-12-31 |
| Major company event | 8-K | 2023-03-22 | 2023-03-16 |
| Insider trade (amended) | 4/A | 2023-02-28 | 2022-06-06 |
| Insider trade (amended) | 4/A | 2023-02-28 | 2022-10-21 |
| Insider trade | 4 | 2023-02-28 | 2022-06-16 |
| Passive ownership stake (update) | SC 13G/A | 2023-02-13 | - |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Insider trade | 4 | 2023-02-02 | 2023-01-31 |
| Insider trade | 4 | 2023-01-23 | 2023-01-20 |
| Prospectus supplement | 424B5 | 2022-12-01 | - |
| Passive ownership stake | SC 13G | 2022-12-01 | - |
| EFFECT | - | 2022-11-29 | - |
| Company correspondence | CORRESP | 2022-11-23 | - |
| SEC correspondence | UPLOAD | 2022-11-22 | - |
| S-3/A | - | 2022-11-16 | - |
| Securities registration | S-3 | 2022-11-15 | - |
| Quarterly report | 10-Q | 2022-11-10 | 2022-09-30 |
| Major company event | 8-K | 2022-11-10 | 2022-11-10 |
| New insider ownership | 3 | 2022-11-09 | 2022-11-08 |
| Insider trade | 4 | 2022-11-09 | 2022-11-08 |
| Major company event | 8-K | 2022-11-09 | 2022-11-08 |
| Insider trade | 4 | 2022-11-02 | 2022-10-31 |
| Insider trade | 4 | 2022-10-25 | 2022-10-21 |
| Major company event | 8-K | 2022-10-21 | 2022-10-21 |
| Insider trade | 4 | 2022-09-16 | 2022-09-14 |
| New insider ownership | 3 | 2022-09-12 | 2022-09-08 |
| Insider trade | 4 | 2022-09-12 | 2022-09-08 |
| Major company event | 8-K | 2022-09-12 | 2022-09-08 |
| Insider trade | 4 | 2022-09-02 | 2022-08-31 |
| Insider trade | 4 | 2022-09-02 | 2022-08-31 |
| Insider trade | 4 | 2022-08-25 | 2022-06-06 |
| Insider trade | 4 | 2022-08-25 | 2022-07-31 |
| Quarterly report | 10-Q | 2022-08-11 | 2022-06-30 |
| Employee stock plan | S-8 | 2022-08-11 | - |
| Major company event | 8-K | 2022-08-11 | 2022-08-11 |
| Passive ownership stake | SC 13G | 2022-07-08 | - |
| Major company event | 8-K | 2022-06-13 | 2022-06-08 |
| Insider trade | 4 | 2022-06-10 | 2022-06-08 |
| Insider trade | 4 | 2022-06-10 | 2022-06-08 |
| Insider trade | 4 | 2022-06-10 | 2022-06-08 |
| Insider trade | 4 | 2022-06-10 | 2022-06-08 |
| Insider trade | 4 | 2022-06-10 | 2022-06-08 |
| Proxy materials | DEFA14A | 2022-05-17 | - |
| Quarterly report | 10-Q | 2022-05-10 | 2022-03-31 |
| Major company event | 8-K | 2022-05-10 | 2022-05-10 |
| Insider trade | 4 | 2022-05-03 | 2022-04-30 |
| Proxy materials | DEFA14A | 2022-05-02 | - |
| Proxy statement | DEF 14A | 2022-05-02 | 2022-06-08 |